CD44 and cholangiocarcinoma: Our results on early stage CCA patients show that patients with a low T stage, absence of lymph node involvement and no distant metastases but with recurrence had higher soluble levels of CD44, CD44v6, CD44v8-10 and EpCAM compared with those patients without recurrence.